Ultralife Corp banner

Intrinsic Value

The intrinsic value of Ultralife Corp (ULBI) under the Base Case is 6.046 USD per share. Compared with the current market price of 15.625 USD, the stock appears Overvalued by 61% .

The intrinsic value is calculated using the DCF method. Net margin recovers from -3.1% last year to 3.3% by 2031. If net margin stayed at its five-year average of 1%, the estimate would be about $1.96.

Do our valuations actually work? See backtest results .

ULBI Intrinsic Value
$6.046
Overvaluation 61%
Intrinsic Value
Price $15.625

ULBI is more expensive than usual. This is its most expensive valuation in the past 5 years.

Monitor ULBI
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $4.84
Get notified when the price drops into your buy zone
Current Price $15.63
Intrinsic Value $6.05
Margin of Safety 20% $4.84
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to ULBI

Fundamental Analysis

What Ultralife Does

Electrical Equipment Industrials

Ultralife Corp makes batteries, battery packs, and backup power systems. Its products are used in places where reliable power matters, such as military equipment, emergency communications, industrial devices, and specialized medical and security gear. The company also sells charging systems and accessories that help customers store, manage, and deliver power in the field.

Headquarters
United States of America US
Employees
678
IPO date
Dec 23, 1992
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ultralife Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

ULBI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ULBI stock?

The intrinsic value for Ultralife Corp (ULBI) under the Base Case is 6.046 USD.

Is ULBI stock undervalued or overvalued?

Compared with the current market price of 15.625 USD, the stock appears Overvalued by 61% .

Back to Top